A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19
Clinical trial NCT05616728 · COMPLETED
Trial details
- NCT number
- NCT05616728
- Sponsor
- Enanta Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-10
- Primary completion
- 2023-02-08
- Enrollment
- 231
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.